By Abigail Townsend
Date: Tuesday 23 Mar 2021
(Sharecast News) - A cocktail of antibodies developed by Roche and Regeneron Pharmaceuticals to treat Covid-19 has been shown to cut hospitalisation or death by 70%, the Swiss drugmaker said on Tuesday.
By Alexander Bueso
Date: Tuesday 26 Jan 2021
(Sharecast News) - Regeneron Pharmaceuticals antibody cocktail severely curtails Covid-19 symptoms and infections, the results of a late-stage trial showed.
By Alexander Bueso
Date: Wednesday 30 Sep 2020
(Sharecast News) - Early trial results for Regeneron's monoclonal antibody cocktail showed that it helped to alleviate symptoms in patients in mild-to-moderate cases of Covid-19.
| Currency | US Dollars |
| Share Price | $ 763.23 |
| Change Today | $ -13.08 |
| % Change | -1.68 % |
| 52 Week High | $787.32 |
| 52 Week Low | $490.81 |
| Volume | 835,671 |
| Shares Issued | 107.80m |
| Market Cap | $82,276m |
| RiskGrade | 129 |
| Strong Buy | 9 |
| Buy | 10 |
| Neutral | 7 |
| Sell | 2 |
| Strong Sell | 0 |
| Total | 28 |

| Time | Volume / Share Price |
| 15:59 | 112 @ $763.21 |
| 15:59 | 80 @ $763.00 |
| 15:59 | 40 @ $762.81 |
| 15:59 | 40 @ $762.84 |
| 15:59 | 40 @ $763.05 |
You are here: research